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M813 is a type-C murine leukemia virus (MuLV) isolated from the Asian rodent Mus cervicolor. We have recently
demonstrated that M813 defines a distinct MuLV receptor interference group. Here we show that M813 rapidly induces
fusion of MuLV-expressing fibroblasts from “without,” with syncytia being observed within 1 h after exposure to virus.
Infection of fibroblasts with MuLV from all tested receptor-interference groups imparts susceptibility to M813-induced fusion,
provided the cells also express the M813 receptor. Syncytium induction is also observed in vivo; mice infected with M813
develop a peripheral T-cell lymphoma, which is associated with large multinucleated cells of macrophage origin. A
recombinant Moloney MuLV/M813 chimeric virus demonstrated that syncytium induction is a function of the Env SU protein.
We postulate that the highly fusogenic property of M813 is attributable to either its unique receptor usage or sequences in
the proline-rich domain of the Env protein. © 2001 Academic PressKey Words: type-C MuLV; syncytium formation; fusogenicity; Env protein; Mus cervicolor; endogenous retrovirus; T-cell
lymphoma.
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cINTRODUCTION
Retroviruses are associated with a wide variety of
diseases, including leukemias, immunodeficiencies, and
neurological disorders. The study of these diseases has
uncovered a wide variety of pathogenic mechanisms,
either shared by several different retroviruses or
uniquely associated with a particular virus (for a review
see Rosenberg and Jolicoeur, 1997). For instance, al-
though oncogene activation by insertional mutagenesis
is a key event in the generation of leukemia by murine
leukemia viruses (MuLVs), leukemia induction by the
human T-cell leukemia viruses (HTLV) is most likely ini-
tiated by cis-activation of cellular regulatory genes by the
accessory protein Tax (Mesnard and Devaux, 1999). Sim-
ilarly, the induction of an immune deficiency by the hu-
man immunodeficiency virus (HIV) has been attributed to
the interaction of its accessory protein Nef with cellular
proteins (Harris, 1996). In contrast, a truncated version of
the structural Gag protein has been shown to be the
critical component of the MAIDS virus, responsible for
the induction of a lymphoproliferative and autoimmune
disease in mice (Huang et al., 1989; Pozsgay et al., 1993).
A glycosylated form of Gag has also been shown to alter
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39disease latency and specificity of MuLV (Corbin et al.,
1994; Fujisawa et al., 1998; Portis et al., 1994).
The importance of env gene products in retroviral
athogenicity is found at several different levels. First of
ll, retroviral entry, and thus target cell specificity, is
ediated by the Env protein complex, composed of a
urface subunit (SU), implicated in receptor recognition,
nd a transmembrane subunit (TM), which harbors a
usion peptide (Hunter, 1997). Thus the disease specific-
ty of HIV is determined by its restricted tropism to cells
f the immune system. In the case of MuLV pathogenic-
ty, it has been shown that generation of recombinant env
ene viruses through recombination of ecotropic MuLVs
ith endogenous polytropic sequences is an important
tep in leukemia induction, presumably by increasing
oth the number of infections per cell (by overcoming the
lock to superinfection) and the number of available
arget cells (by stimulating lymphohematopoietic hyper-
lasia of the spleen) (Brightman et al., 1990; Li and Fan,
991)—the consequence of which is an increase in the
robability of oncogene activation. The direct interaction
f the Env protein with either its own cellular receptor or
ther transmembrane proteins has also been shown or
ostulated in disease pathogenicity, by either disrupting
r activating the normal function of the protein (e.g.,
timulation of the erythropoietic receptor by the trun-
ated Env protein of the Friend spleen focus-forming
irus, ultimately resulting in the induction of erythroleu-
emia) (Hoatlin et al., 1990; Li et al., 1990) or a proposed
0042-6822/01 $35.00
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40 PRASSOLOV ET AL.disruption of the transporter function of either ecotropic
or amphotropic MuLV receptors in glial cells of the cen-
tral nervous system, leading to the observed spongiform
encephalomyelopathy (Kay et al., 1993; Mu¨nk et al.,
998). Finally, Env-induced syncytium formation has been
ostulated to be a mechanism by which HIV induces cell
eath of uninfected cells, which is supported by the
bservation that the appearance of syncytium-inducing
IV variants accelerates the course of the disease (Jur-
iaans et al., 1994; Tersmette et al., 1988). Multinucleated
iant cells are also a hallmark of encephalitis induced by
oth HIV and simian immunodeficiency virus (Geleziunas
t al., 1992; Simon et al., 1994). The ability of retroviruses
o induce cell fusion is thought to be regulated by the
ame mechanisms that govern viral cell entry: receptor
ecognition by the SU induces conformational changes
hat unmask fusion determinants in the TM.
M813-MuLV was originally isolated from lung cells
erived from the Asian rodent Mus cervicolor. We have
ecently shown that M813 defines a unique MuLV inter-
erence group (Prassolov et al., 2001). The lack of infec-
tion interference with other MuLVs supports the use of a
unique cellular receptor for cell entry. Molecular cloning
and sequencing of the env gene further support this
contention: the variable region A (VRA) in the SU domain,
important in determining receptor binding, is distinct
from that of other MuLVs. The host range of M813 is quite
restricted, with efficient infection being observed only in
rodent cells derived from Mus musculus (Benveniste et
al., 1977; Prassolov et al., 2001).
In the course of characterizing M813, we observed a
high fusogenic potential of the virus. The studies pre-
sented here were designed to more closely define the
conditions necessary for induction of syncytium forma-
tion by M813 and to determine whether this fusogenic
potential of M813 also contributed to the pathogenicity of
FIG. 1. M813 infection induces fusogenicity of MuLV-infected cells in
Giemsa staining. Magnification, 1503.the virus. We established that M813 induces a T-cell
lymphoma in vivo, similar to but distinct from that ob-served by other MuLVs. Significantly, large multinucle-
ated cells were often associated with the tumor, demon-
strating that M813 fusion induction is not limited to in
vitro cultures. Based on a M813 env recombinant virus,
we postulate that the high fusogenicity of M813 is attrib-
utable to either its unique receptor usage or unique
sequences in the proline-rich domain of the SU.
RESULTS
M813-MuLV induces syncytium formation in PA317
In an experiment initially designed to generate
M813(Ampho)-MuLV pseudotypes to infect human cells,
PA317 amphotropic packaging cell lines were inoculated
with supernatant from murine SC1 cells expressing
M813. Within 1 h after exposure to retrovirus, clear signs
of syncytium formation between PA317 cells were ob-
served in the cultures. After 4 h, almost all cells in the
culture were fused (Figs. 1A and 1B), resulting in the
death of the culture within 24 h. Although the addition of
polybrene to the culture accelerated the fusion process,
it was neither necessary nor singly able to induce fusion
of PA317 cells (data not shown).
To obtain a closer view of the cell fusion process,
electron microscopic methods were employed. Cell cul-
ture monolayers were incubated in the cold with cell
culture supernatants rich in M813 virus particles. After
extensive washing, the cultures were either fixed imme-
diately or incubated further for 30 to 120 min at 37°C.
Replicas prepared immediately after exposure of PA317
cells to virus-bearing supernatant demonstrated numer-
ous cells with irregular contours and complex surface
structures. The average length of the elongated cells that
exhibited slightly folded cell membranes bearing numer-
ous microvilli was 25–30 mm (Fig. 2a). Adhering virus
particles could be detected primarily at the glass sur-
) PA317 cells incubated with M813 for 4 h. (B) Uninfected PA317 cells.face, but were also seen attached to the microvilli (Fig.
2a). After incubation of the virus-exposed cell cultures for
f
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o
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41M813-MuLV IS HIGHLY FUSOGENICmore than 60 min at 37°C, a striking alteration of the cell
morphology occurred: the cells became flattened and
their processes gradually disappeared. Two hours after
the temperature shift, only a few prominent short mem-
brane ruffles and very few microvilli were present (Fig.
2b). Moreover, delimitation between individual cells at
contact points became obscured due to partial membrane
fusions, with the consequence that cell borders were more
and more difficult to distinguish (Figs. 2c and 2d).
These kinetics indicate that fusion occurs from “with-
out,” i.e., when a single virion simultaneously fuses with
two cells, in contrast to the fusion observed when XC
FIG. 2. Ultrastructural aspects of M813 virus-induced cell fusion as
ibroblast after incubation for 30 min at 4°C with medium containing M8
rrow points to virus particles attached to microvilli. (b) Further incuba
nd considerable reduction of microvilli. Note the prominent membrane
f two adjacent cells (extending from the arrow to the upper margin o
ndicated by the arrow in C. Magnification bar represents 1.0 mm.sarcoma cells are infected with Moloney MuLV (Mo-
MuLV) (Klement et al., 1969), which occurs from “within,”i.e., when an infected cell expressing Env on its cell
surface fuses with an adjacent cell (White et al., 1983).
M813-MuLV and not MuLVs of other interference
groups induces fusion of PA317 cells
Several experiments were carried out to determine
whether the observed fusogenicity with M813-infected
PA317 cells was a particular characteristic of the PA317
cells, the M813 virus, or both. In all experiments, equal
numbers of the target cell were plated and exposed to
virus supernatants with defined titers. After 4 h, cultures
by replica preparation technique. (a) Cell surface replica of a PA317
s. Numerous microvilli extend from the slightly folded cell surface. The
120 min of PA317 cell cultures at 37°C results in a flattened cell body
(c) This electron micrograph shows partially fused plasma membranes
icture). (d) Higher magnification of the cell membrane fusion processshown
13 viru
tion for
ruffles.
f the pwere assessed for syncytium formation and the fusion
index (FI) was determined using the formula (N 2 S)/T,
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42 PRASSOLOV ET AL.where N is the number of nuclei in a syncytium, S is the
umber of syncytia, and T is the total number of nuclei
Andersen, 1994). Over 500 nuclei were counted in each
xperiment to obtain the FI value.
We first established that, whereas the PA317 cells
eadily formed syncytia after exposure to M813, no syn-
ytium induction was observed in NIH3T3 cells, from
hich the PA317 cells are derived (an FI of 78% for PA317
ersus an FI of 6% for NIH3T3 cells; average of two
ndependent experiments). This suggested that the ex-
ression of amphotropic Env proteins or other viral pro-
eins may be important for fusion induction.
In a second set of experiments, we tested whether
uLVs of other receptor groups, namely, the ecotropic
o-MuLV, which uses mCAT1, or alternatively, 10A1-
uLV, which uses Pit1 and Pit2 for cell entry, would also
nduce syncytium formation of PA317 cells. No cell fusion
as observed when PA317 cells were exposed to 10A1-
uLV. Some fusion was observed with the ecotropic
o-MuLV, but significantly less than that observed with
813 (Table 1). Whereas syncytia with up to 18 nuclei
ere observed with M813, at most 2 to 3 nuclei per
yncytium were observed with MoMuLV. Thus, both the
A317 cell line and the M813 virus itself contribute to the
igh degree of fusogenicity observed.
813 induces fusion of cells infected with different
uLVs, but infection of M813-expressing cells with
ther MuLVs does not result in syncytium formation
It is likely that expression of the amphotropic Env
rotein in PA317 cells contributes to the altered fuso-
TABLE 1
M813, but Not Other MuLVs, Is Highly Fusogenic
in PA317 Cell Cultures
Virus
Titera
(GTU)
Fusion index (%)
on target cellb
NIH 3T3 PA317
813-MuLV 1.4 3 104 6 6 4.2 78 6 12
0A1-MuLV 7.8 3 104 3 6 1.4 4 6 0.3
Mo-MuLV 3.6 3 104 4 6 0.6 25 6 2.8
a The virus titer of the supernatant used to inoculate the cell cultures
as determined by marker rescue using the retroviral vector MPEV-
eoR. The number of G418-resistance transfer units (GTU) was deter-
ined by end-point dilution of virus, infection of SC1 cells, and selec-
ion under G418.
b The fusion index (FI) was determined using the formula (N 2 S)/T,
where N is the number of nuclei in a syncytium, S is the number of
yncytia, and T is the total number of nuclei (Andersen, 1994). Over 500
nuclei were counted in each experiment to obtain the FI value. The
average values with standard deviations (6SD) from two independent
experiments are shown.enic properties of the cell line. It was therefore of
nterest to determine whether this was a particular prop- aerty of amphotropic Env sequences or whether the ex-
pression of other MuLV Envs would also alter the fuso-
genicity of the cell. SC1 mouse fibroblasts expressing
different MuLVs representing four different receptor in-
terference groups (e.g., ecotropic, polytropic, ampho-
tropic, and 10A1) were tested for their fusogenicity after
incubation with M813. Although SC1 fibroblasts did not
form syncytia upon exposure to M813-MuLV, all cell lines
expressing any one of the other MuLVs were highly
fusogenic when exposed to M813 (Table 2). These re-
sults show that expression of the amphotropic Env is not
unique in its ability to “prime” cell fusion, but rather either
all MuLV Env proteins have this function or other viral
proteins (e.g., Gag proteins) common to the MuLVs used
in this assay are responsible for the priming of cell fusion
in NIH 3T3 fibroblasts.
We next sought to determine whether SC1 fibroblasts
infected with M813 would become susceptible to fusion
with other MuLVs. SC1-M813 cells were thus incubated
with either Mo10A1V or MoMuLV and monitored for cell
fusion. No fusion above background levels was ob-
served in these cultures, even when observed 48 h after
infection (data not shown). In conclusion, expression of
M813 in SC1 cells does not make them permissive for
fusion from either within or without with either ecotropic
or 10A1 MuLVs.
M813 susceptibility is a prerequisite for fusion
induction
Human cells are not permissive for M813 infection,
presumably because they lack the M813 receptor for cell
entry. It would be expected that M813-induced fusion is
mediated through interaction with its cell receptor. To
test this, human cells were incubated with M813. To
increase the likelihood that fusion would be observed,
retroviral-packaging cell lines of human origin express-
ing MoMuLV Pol and Gag proteins, as well as the Env
proteins of MoMuLV (TE-FLY-Mo), amphotropic 4070-
MuLV (293-Phoenix-Ampho), or the gibbon ape leukemia
virus (TE-FLY-GALV), which shares a common receptor
TABLE 2
MuLV Expression Makes SC1 Cells Permissive
to M813-Induced Fusion
Target cell in
culture
Fusion index (%)a
Uninoculated M813 inoculated
SC1 2.4 6 0.7 5.4 6 0.3
SC1 1 MoMuLV 0.8 6 0.14 94.0 6 5.7
SC1 1 MoMCFV 1.6 6 0.6 73.2 6 15.6
SC1 1 MoAmphoV 2.0 6 0.6 70.1 6 8.0
SC1 1 Mo10A1V 2.8 6 0.01 77.4 6 11.9a The fusion index was calculated as stated in Table 1. The aver-
ge 6 SD of two independent experiments is shown.
a43M813-MuLV IS HIGHLY FUSOGENICwith 10A1-MuLV, were tested. As shown in Table 3, M813
did not induce fusion of any of these cells.
M813 SU sequences are sufficient to impart high
fusogenicity to the ecotropic MoMuLV
To ascertain whether the unique receptor usage of
M813 was important in the fusogenic property of M813, a
chimeric virus was tested in which the MoMuLV se-
quences encoding the majority of the mature SU protein
[including the complete binding recognition domain
(VRA, VRB, and VRC) and the proline-rich domain] but not
the TM protein were replaced with those of M813 (Fig. 3).
Although titers were somewhat lower than in previous
assays (2 3 103 G418-resistance transfer units per mil-
liliter), syncytium formation was readily observed when
PA317 cells were incubated with the recombinant virus. A
fusion index of 61.3 was calculated (average of two in-
dependent experiments). Although somewhat lower than
that observed for wild-type M813 (79.3), this most likely
reflects the lower virus titer.
M813-MuLV-infected mice develop T-cell lymphomas
containing multinucleated syncytia
The high fusogenicity of M813-MuLV observed in vitro
prompted us to determine whether this property would
TABLE 3
Human Cells Expressing MuLVs Do Not Form Syncytia
after M813 Infection
Target cell in
culture
Fusion index (%)
Uninoculated M813-inoculated
TE671 1.6 6 0.2 4.2 6 0.15
TE-FLY-GALV 7.8 6 0.3 6.5 6 0.4
TE-FLY-MO 8.4 6 0.57 6.8 6 0.32
293 ,10b ,10b
293-Phoenix-Ampho ,10b ,10b
a The fusion index was calculated as stated in Table 1. The aver-
ge 6 SD of two independent experiments is shown.
b The fusion index was not calculated in this set of experiments, but
was similar to that of other cell lines. No difference was observed
between noninfected and M813-infected cultures.
FIG. 3. Schematic diagram of the MoMuLV/M813 (MoM813V) chim
induction of M813. Shaded areas in SU are those derived from M813, w
(VRA, VRC, and VRB, respectively) are boxed with diagonal lines, and the pro
of TM is indicated by a black box.also be reflected in its pathogenicity in vivo. Within 36 h
after birth, either DBA/2J or DDD mice were infected with
M813-MuLV produced from SC1 cells (n 5 8 and n 5
12, respectively). Between 9 and 12 months after infec-
tion for DDD mice and 13 and 18 months for DBA/2J,
approximately 75% of the mice were moribund, in con-
trast to uninfected controls that remained asymptomatic
within this time frame. Examination of sacrificed animals
revealed hepatosplenomegaly (spleen weights between
0.7 and 1.5 g, as compared to 0.08 g in uninfected
controls) accompanied by enlarged, tumorous lymph
nodes. Large mesenteric lymphomas (.600 mg) were
observed in all animals that were more closely examined
(6/6). Significantly, no enlargement of the thymus was
observed in any of these animals.
Histological examination of M813-infected DDD and
DBA mice revealed a peripheral T-cell lymphoma of
lymph nodes (Fig. 4A) and spleen, metastasizing prefer-
entially to the liver (Fig. 4B). Involvement of other organs
was rare. The lymphomas presented with effacement of
lymph node and splenic architecture, a nodular to diffuse
growth pattern, and invasion of perinodular tissue. The
neoplastic cells ranged from small lymphocytes to large
bizarre cells, but appeared mostly as medium to large
lymphoid cells with nuclear atypias and abundant cyto-
plasm (Fig. 4A). Apparently, the peripheral T-cell lympho-
mas transformed to an anaplastic large cell lymphoma in
the final stages of the disease (Fig. 4B). The lymphocytic
tumor cell population consistently exhibited a positive
CD3 immunoreactivity (Fig. 4C), confirming the T-cell
origin. A distinct feature of T-cell lymphomas of M813-
infected DDD mice—as revealed by immunocytochemi-
cal tagging—was the admixture of numerous mature
and immature granulocytes, preplasma and plasma
cells, dendritic cells, and histiocytes to the neoplastic
lymphoid cells (data not shown).
Strikingly, very large, multinucleated syncytia with non-
distinctive cell boundaries (Fig. 4D) and more typical
multinucleated giant cells (Fig. 4E) were observed in
both the medullary and the extracapsular invasion zones
of these lymphomas, as well as in the expanded periar-
terial lymphocyte sheath of the splenic white pulp. Oc-
casionally, more than 50 nuclei could be counted per
rovirus used to determine the sequences responsible for the fusion
s all other sequences are derived from MoMuLV. The variable regionseric ret
herealine-rich domain is boxed with vertical lines. Transmembrane domain
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44 PRASSOLOV ET AL.syncytium. Syncytia formation seemed to be a transient
phenomenon, since syncytia undergoing necrosis (apo-
ptosis) could be observed, indicating their limited viabil-
ity. Because of their positive S100 and lysozyme immu-
nostaining, the multinucleated structures are probably of
macrophage and/or dendritic cell origin (Fig. 4F). How-
ever, the extensive syncytia are morphologically clearly
distinct from conventional multinucleated giant cells,
which are a well-known reactive form of mononuclear
phagocytes in response to diverse stimuli. Using anti-
body against SUgp70, MuLV env expression could be de-
ected in CD3-positive lymphoma cells and macro-
hages, as well as in the syncytia, but in no other cell
FIG. 4. Histopathology of M813 virus-induced lymphomas. (A) Perip
infiltrating the liver. (C) CD3 immunostaining of peripheral T-cell lymph
Multinucleated giant cells of a peripheral T-cell lymphoma. (F) S100
hematoxylin and eosin (B, D, and E). Magnification: 3803 (A, B, and Dypes (data not shown). This confirms that both the lym-
hoid transformation and the syncytia formation were
r
mnduced by M813-MuLV and/or MCF recombinants gen-
rated by the M813 infection.
DISCUSSION
M813 is a type-C MuLV that defines a novel receptor
nterference group. Similar to ecotropic MuLVs, the M813
ost range is restricted to rodent cells. However, our
tudies have clearly shown that M813 uses a cellular
eceptor distinct to both the CAT1 protein, used by the
cotropic MuLVs, and receptors used by other charac-
erized MuLVs (Prassolov et al., 2001). In the studies
resented here, we have shown that M813 readily in-
uces cell fusion in vitro and in vivo. Electron microscopy
-cell lymphoma of a lymph node. (B) Anaplastic large cell lymphoma
D) Large multinucleated syncytium of peripheral T-cell lymphoma. (E)
ostaining of multinucleated giant cells. Stains were Giemsa (A) and
(C), 2903 (E), and 5803 (F).heral T
oma. (evealed the adherence of virus particles to the fusing
embranes and demonstrated the rapid changes in the
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45M813-MuLV IS HIGHLY FUSOGENICcellular membrane following exposure to the virus. Syn-
cytium formation was observed only between cells that
expressed the M813 receptor and that were made per-
missive for cell fusion by expression of an MuLV. Analy-
sis of a chimeric Env protein showed that the M813 SU
protein dictated its high fusogenicity. This unique prop-
erty of M813 was also reflected in its pathogenicity.
Histological examination of lymphomas induced by M813
in infected DDD mice revealed large multinucleated
cells. Unlike lentiviral and oncoviral infection of humans,
retroviral MuLV infections of mice are normally not as-
sociated with the development of multinucleated syn-
cytia. Thus, whereas the transformation of the lymphoid
cells is probably the result of oncogene activation by
insertional mutagenesis of M813-MuLV or MCF recom-
binants, the multinucleated syncytia are most likely in-
duced by direct binding of M813 to its receptor on these
cells, providing evidence that the fusogenic capacity of
the M813 retrovirus is not restricted to cell culture con-
ditions but is also effective in vivo.
The ability of a virus to induce cell fusion is dictated by
several factors, inherent both to the virus itself and to the
cellular environment. Retroviruses reported to induce
cell-to-cell fusion include feline viruses [feline leukemia
virus and RD-114 (Hampar et al., 1973)], the avian retic-
uloendotheliosis virus (Delwart and Panganiban, 1989),
and both the human viruses HIV and HTLV (Freed et al.,
1990; Poon and Chen, 1998; Tersmette et al., 1988). For
he murine retroviruses, fusion induction has been re-
orted for the mouse mammary tumor virus and the
cotropic MuLVs under limited conditions (Andersen,
994; Jones and Risser, 1993; Klement et al., 1969; Pinter
t al., 1986; Siess et al., 1996; Wilson et al., 1992).
What are the Env determinants of M813 that render it
highly fusogenic? Hydrophobic fusion peptides that
share many features of the well-characterized fusion
peptide of influenza virus (White, 1992) have been de-
fined in the extracellular domain of the TMs of HIV and
MuLV (Freed et al., 1990; Jones and Risser, 1993). In
ddition, sequences in the cytoplasmic domain of the TM
nd at the amino-terminus of the SU have been shown to
e essential for virus–cell fusion (Bae et al., 1997; Janus-
eski et al., 1997). It is believed that binding of the SU to
ts receptor results in conformational changes in the TM
hat activate the fusion peptide. Conceivably, a unique
tructure of the M813 TM may increase its fusogenic
apacity. Our data found this unlikely, as a MoMuLV/
813 Env recombinant, in which the entire TM was
erived from MoMuLV, was also fusogenic. These re-
ults are also consistent with earlier results comparing
he increased fusogenicity of the ecotropic MoMuLV with
mphotropic MuLV; swapping TMs did not alter the fu-
ogenic potential of either virus (Ragheb et al., 1995). In
ontrast, sequences in the proline-rich region of SU in
oMuLV were shown to impart high fusogenicity to an
mphotropic Env (Andersen, 1994; Lavillette et al., 1998).
H
nhis region has been proposed to participate in the
usion process by regulating the transition between the
onformational changes that occur in the Env glycopro-
ein before and after receptor binding (Lavillette et al.,
998). Domain swapping between other MuLV Env pro-
eins is required to determine whether the M813 proline-
ich domain can impose increased fusogenicity to other
nv proteins.
The number of receptors expressed on the cell surface
s also a critical parameter in virus-induced cell fusion.
he level of syncytium formation was found to correlate
ith either mCAT1 or Pit1 receptor levels in CHO cells
nfected with either ecotropic or amphotropic viruses,
espectively (Siess et al., 1996). These results suggest
hat receptor clustering is the limiting step in syncytium
ormation, which can be modulated by both receptor
umbers and unknown cellular factors. The cellular re-
eptor of M813 is unknown, but could be a molecule that
s expressed at high levels in fibroblasts or in macro-
hages and thus account for the observed fusion in vitro
nd in vivo. The primary receptor binding domain of other
uLVs resides in the variable regions VRA and VRB in
he amino-terminus of the SU (Battini et al., 1992, 1995;
ass et al., 1997; Heard and Danos, 1991). Substitution of
nly this domain from M813 with that of another MuLV
ill help determine whether the receptor itself is impor-
ant in the cell fusion process.
In addition to parameters dictated by the virus, several
ellular factors are also important in determining the
usogenic potential. Earlier studies have clearly shown
hat oncogenic transformation can make a cell more
ermissive for virus-induced fusion (Kaufman and Ehr-
ar, 1980; Klement et al., 1969; Wilson et al., 1992). The
eason for this is unclear, but may be related to in-
reased levels of receptor expression or, alternatively,
ltered posttranslational processing of the receptor,
uch as glycosylation. Glycosylation levels on the recep-
or have been shown to have a dramatic effect on the
bility of a virus to infect a cell (Miller and Miller, 1992;
ilson and Eiden, 1991). Furthermore, the level of recep-
or glycosylation has been found to correlate with syn-
ytium formation in several studies (Andersen, 1994;
ones and Risser, 1993). Alternatively, sensitivity to cell
usion in transformed cells may be due to changes in the
lasma membrane associated with malignant transfor-
ation, including changes in the cytoskeleton.
In the study presented here, the expression of MuLV
roteins imparted sensitivity to M813-induced syncytium
ormation. As Env expression appeared to be a likely
xplanation for this altered phenotype, we tested
hether Env proteins from different MuLV receptor
roups had the same effect. No difference in the ac-
uired fusogenicity was observed when Envs of ampho-
ropic, ecotropic, 10A1, or polytropic viruses were used.
ow might Env expression impart an increased fusoge-
icity to fibroblasts? Expression of the Env protein on the
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46 PRASSOLOV ET AL.cell surface would allow it to interact with receptor ex-
pressed on neighboring cells. Normally, this interaction
is probably not sufficient to induce cell fusion, as activa-
tion of the fusion peptide in MuLV requires not only
binding of the SU with the cellular receptor, but also
cleavage of the p2E peptide on the TM precursor
(pre15E) by the viral protease to yield the mature TM
protein (p15E) (Ragheb and Anderson, 1994; Rein and
Schultz, 1984; Zhao et al., 1998). As this occurs within the
iral particle, only the immature form is expressed on the
ell surface. However, this receptor–Env interaction ei-
her may facilitate cell–cell interaction, thereby increas-
ng the likelihood that the M813 virus particle comes in
ontact with more than one cell, or may already have
nduced changes in the cell membrane that generally
ake it permissive to cell fusion. Importantly, we cannot
urrently exclude the possibility that other viral proteins,
uch as Gag, that assemble at the cell membrane also
mpart changes to the cell membrane and thus its sen-
itivity to cell fusion.
The increased fusogenicity of M813 prompted us to
etermine whether this property would be reflected in its
athogenicity. Similar to the other MuLVs, we found that
813 induced T-cell lymphomas in infected mice. This
isease is distinct from that induced by the ecotropic
oMuLV, in that the retarded course of the tumor dis-
ase is associated with the development of a peripheral
nstead of a central T-cell lymphoma. A remarkable fea-
ure of the M813-induced T-cell lymphoma is the pro-
ounced infiltration of nonneoplastic cells, such as gran-
locytes, dendritic cells, and macrophages, the last of
hich apparently give rise to extensive yet transient
yncytia formation. The admixture of various other hema-
opoietic cell elements to neoplastic lymphocytes is also
hallmark of the human lymphoma category of “periph-
ral T cell lymphomas, unspecified,” as recently defined
n the new WHO classification of human lymphomas
Jaffe et al., 1999). Noteworthy was the occurrence of
large multinucleated cells in the periphery of the tumor-
igenic growth, demonstrating that the fusogenicity of
M813 also influences its pathogenicity. Similar findings
have been found for the TR1.3 MuLV, which induces
syncytium formation of endothelial cells both in vitro and
in vivo; inoculation of neonatal mice uniformly induces
cerebral infarctions and hemorrhages due to fusion of
cerebral vessel endothelial cells (Park et al., 1994a,b).
The long latency of M813 disease induction (.1 year)
may reflect the importance of secondary mutations
and/or the generation of recombination events with en-
dogenous MuLVs. Indeed, preliminary analysis of
genomic DNA derived from tumors has revealed M813-
recombinant proviruses (C.S., unpublished results). We
postulate that recombination with endogenous polytropic
sequences generates replication-competent MuLVs that
synergize with M813 in inducing lymphomas. Cells ex-
pressing a polytropic MuLV may be primed for fusion
(
tinduction by M813 or M813 recombinants carrying the
M813 SU domain, as we have observed in vitro.
In conclusion, we have shown that M813 can readily
induce syncytium formation in permissive cells. This
unique property of M813 resides in the SU domain of the
Env glycoprotein. Molecular cloning of the M813 receptor
should shed light on its role in fusion induction. In addi-
tion, the generation of Env chimeras will lead to the
identification of sequences in the SU domain that facili-
tate this process. Numerous attempts have been made
to alter the tropism of type C MuLVs (Cosset and Russel,
1996). Although extension of the amino-terminus of MuLV
Envs with different ligand types, such as single-chain
antibodies and cytokines, has been generally success-
ful, infectivity has been intrinsically poor due to low
fusogenicity. Understanding the mechanism by which
M813 SU sequences increase fusogenicity may help
eliminate this problem.
MATERIALS AND METHODS
Viruses, cell lines, and cell culture
SC1 fibroblasts were used as virus producers in all
experiments. SC1 cells expressing M813 were obtained
by infection of SC1 cells with the supernatant of M813
(NIH), kindly provided by U. Rapp (Rapp and Marshall,
1980). SC1 or SC1-MPEVneoR cells expressing MoMuLV,
MoAmpho, Mo-MCFV, and Mo10A1V have been previ-
ously described (Prassolov et al., 2001). The NIH3T3-
based packing cell line PA317 was obtained from A. D.
Miller and produces an amphotropic Env (Miller and
Buttimore, 1986). The human TE671 cell line is the basis
of the two packaging cell lines, TE-FLY-GA16 and TE-FLY-
MO, producing the Env proteins from GALV and Mo-
MuLV, respectively, and were kindly provided by L. F.
Cosset (Cosset et al., 1995). The Phoenix-Amphotropic
packaging cell line, provided by G. Nolan, is based on
the human embryonic kidney 293 cell line and expresses
the amphotropic Env protein. All cells were grown in
Dulbecco’s modified Eagle9s medium with 10% fetal bo-
vine serum. The MoM813V recombinant used in this
study has been previously described (Prassolov et al.,
2001).
Virus titers and syncytia assays
Virus titers were determined either by end-point dilu-
tion (1:5) on SC1 cells and detection by immunohisto-
chemistry or by a marker rescue assay. A rabbit antibody
against CAp30 (1:150) was used to detect positively in-
ected cells (kindly provided by P. Nobis, Munich, Ger-
any), and was visualized by FITC-labeled goat anti-
abbit secondary antibody (1:80; Biosource International,
amarillo, CA) using a modified method of Wilson et al.1994). Marker assays were performed in the case where
he virus was produced from SC1-MPEVneoR cells,
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47M813-MuLV IS HIGHLY FUSOGENICwhich carry a retroviral vector conferring resistance to
G418 (Laker et al., 1998). Two days after infection of SC1
ells, G418 (400 mg/ml) was added. After 10 to 14 days,
eoR colonies were counted.
To determine the fusion index, cells were seeded at a
oncentration of 2–3 3 105 cells per well in six-well
plates. Twenty-four hours later, medium was replaced
with virus-containing supernatant. Syncytia formation
was visible after 1 h and cells were generally fixed after
4 h and stained with Giemsa’s solution (Sigma). Assays
were normally performed with polybrene (8 mg/ml), un-
ess noted otherwise. At least 500 nuclei were counted
or each experiment.
ouse infections
Within 36 h after birth, DBA/2J or DDD (Fv2s) mice were
nfected intraperitoneally with 75 ml supernatant from
C1-M813 fibroblasts. Virus titers were determined in
arallel on SC1 cells and were 3.9 3 105 per milliliter.
ice were monitored weekly for clinical symptoms. Mor-
bund mice were sacrificed and subjected to histopatho-
ogical analysis.
istologic and immunohistologic methods
Tissue specimens were fixed in 4% formaldehyde con-
aining 1% acetic acid. Deparaffinated sections were
tained with hematoxylin–eosin, periodic acid-Schiff re-
ction, and Giemsa stain according to standard proto-
ols. To demonstrate immunohistochemically the ex-
ression of immunoglobulins, T-cell receptor, myeloper-
xidase, lysozyme, S100 protein, or the MuLV SUenv by
the avidin–biotin complex method (Hsu et al., 1981), a
panel of polyclonal antibodies was used: rabbit anti-
mouse k and l light chains (Nordic, Tilburg, The Neth-
rlands), goat anti-mouse m heavy chain (Pel-Freez, Rog-
rs, AZ), rabbit anti-human CD3 (Dako Diagnostica, Ham-
urg, Germany), rabbit anti-human myeloperoxidase
Dako), rabbit anti-bovine S100 protein (Dako), rabbit
nti-lysozyme (Biogenex, San Ramon, CA), and goat anti-
Ugp70 (gift from W. Scha¨fer, Tu¨bingen, Germany). For
antigen retrieval, deparaffinated sections were treated
with a commercial “target unmasking fluid” (Dianova,
Hamburg, Germany) in a microwave oven. Incubation
with primary antibodies was done overnight at 4°C.
Bound antibodies were detected with a biotinylated sec-
ondary antibody and subsequent incubation with phos-
phatase- or peroxidase-conjugated streptavidin (Bio-
genex). Visualization of phosphatase activity was done
with naphthol AS-BI phosphate in combination with
hexazotized new fuchsine (Merck, Darmstadt, Germany).
Peroxidase activity was revealed with H2O2 and 3,3-
iaminobenzidine-tetrahydrochloride (Merck). Endoge-
ous avidin-binding activity was reduced by pretreat-
ent of the sections with avidin and biotin solutions
Zymed Laboratories, San Francisco, CA).eplica preparation for electron microscopy (EM)
PA317 cells were seeded on glass coverslips measur-
ng 8 3 50 mm at a density of 5 3 105 cells/ml. Sixteen
hours later, the cultures were washed twice with PBS
and incubated with SC1 tissue culture supernatant con-
taining M813 virus particles for 30 min at 4°C. After
extensive washing, the cultures were either fixed imme-
diately with a cold solution or incubated further for 30, 60,
90, and 120 min at 37°C. For EM preparations, speci-
mens were washed with ice-cold 0.1 mol/L PIPES buffer
(pH 6.9) and fixed in situ for 30 min with 2.5% glutaral-
dehyde in 0.1 mol/L PIPES supplemented with 20 mM
CaCl2. Fixed cells were rinsed with the same buffer and
ostfixed in PIPES-buffered 1% osmium tetroxide for 30
in at 4°C. After extensive washing in PIPES, the cul-
ures were treated for 10 min with 1% tannic acid in
ater, washed, and dehydrated in ethanol. Dehydration
as followed by two short washes with tetramethylsilane
Fluka, Taufkirchen, Germany) (Ting-Beall et al., 1995).
fter being dried for 30 min at 37°C, coverslip fragments
ith appropriate cell density were cut out. Shadow-cast-
ng was done with platinum/carbon at a 45° angle and
arbon at a 90° angle in a Bioetch 2005 (Leybold-
eraeus, Cologne, Germany) cooled at 2100°C. The
hadowed cells were detached from glass in hydroflu-
ric acid and the organic material was digested with a
odium hypochlorite solution. The replicas were
ounted on grids without supporting films and examined
n a Philips CM 120 electron microscope at 80 kV (Ho-
enberg, 1989).
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